Regulatory PathRegulatory requirements compared

Active substance

Wool fat hydrous

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
DURATEARS OCULAR OINT.30.0 mgEye ointment · Topical1 TubeSAR 16.20Generic · PrescriptionALCON N.V.Valid
Indications — CHI Daman Drug Formulary

ALLERGIC CONJUCTIVITIS (AC); ANESTHESIA-SUPPORTIVE AGENTS/ EYE DRYNESS IN PATIENTS RECEIVING CONTINUOUS INFUSIONS OF NEUROMUSCULAR BLOCKERS.; VIRAL CONJUNCTIVITS, HERPESVIRAL KERATITIS, HERPESVIRAL CONJUNCTIVITIS, VARICELLA KERATITIS, ZOSTER CONJUNCTIVITIS, ZOSTER KERATITIS, MEASLES KERATITIS AND KERATOCONJUNCTIVITIS, VIRAL CONJUNCTIVITIS, KERATITIS

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.